Safety and Tolerability of Metronidazole Gel 1.3%
NCT02392026
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
60
Enrollment
INDUSTRY
Sponsor class
Conditions
Vaginosis, Bacterial
Interventions
DRUG:
Metronidazole Gel
Sponsor
Insud Pharma
Collaborators
[object Object]